UTILISATION D'UN VIRUS DE LA ROUGEOLE INFECTIEUX GENETIQUEMENT MODIFIE PRESENTANT DES PROPRIETES PRO-APOPTOTIQUES AMELIOREES (VIRUS MV-DELTAC) POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;UNIVERSITE DE NANTES;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSTITUT PASTEUR

发明人:

TANGY, FREDERIC,GREGOIRE, MARC,FONTENEAU, JEAN-FRANCOIS,GUILLERME, JEAN-BAPTISTE,COMBREDET, CHANTAL

申请号：

CA2898370

公开号：

CA2898370A1

申请日:

2014.01.20

申请国别(地区):

CA

年份:

2014

代理人:

摘要：

The invention relates to a genetically modified infectious measles virus derived from a live-attenuated measles virus strain, in which the gene encoding the viral accessory C protein has been knocked out (MV-deltaC). It concerns in particular the use of said genetically modified infectious MV-deltaC in the treatment of malignant tumour or cancer conditions, and for the preparation of agents or compositions for such treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/